Yogurt & Non-alcoholic fatty liver disease (NAFLD) + Metabolic Syndrome (MetS)

Higher yogurt consumption was inversely associated with the prevalence of newly diagnosed Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD). These results are needed to be confirmed in randomized controlled trials or prospective studies
Zhang et al. 2020z European Journal of Clinical Nutrition 74: 491–499

In addition, a recent human intervention study showed that 24-week consumption of yogurt (220 g/day) improved insulin resistance and reduced liver fat in overweight women with Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD)
Chen et al. 2019 Am. J. Clin. Nutr. 109: 1611–1619

Yogurt was better than milk at ameliorating Insulin resistance and liver fat in obese Chinese women with NAFLD and MetS, possibly by improving lipid metabolism, reducing inflammation, oxidative stress, and Lipopolysaccharides (LPS), and changing the gut microbiota composition.
Chen et al. 2019 Am. J. Clin. Nutr. 109: 1611–1619